These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 37037733

  • 1. Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China.
    Gong Y, Yao X, Peng J, Ma Y, Fang Y, Yan K, Jiang M.
    Am J Prev Med; 2023 Jul; 65(1):155-164. PubMed ID: 37037733
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
    Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA.
    Hum Vaccin Immunother; 2014 Jul; 10(5):1171-80. PubMed ID: 24609063
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
    Nagy L, Heikkinen T, Sackeyfio A, Pitman R.
    Pharmacoeconomics; 2016 Sep; 34(9):939-51. PubMed ID: 27423657
    [Abstract] [Full Text] [Related]

  • 5. [Cost-effective analysis of seasonal influenza vaccine in elderly Chinese population].
    Chen C, Liu GE, Wang MJ, Gao TF, Jia HP, Yang H, Feng LZ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct 06; 53(10):993-999. PubMed ID: 31607044
    [Abstract] [Full Text] [Related]

  • 6. Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis.
    Bianculli PM, Bellier L, Mangado IO, Pérez CG, Mieres G, Lazarov L, Petitjean A, Dibarboure H, Lopez JG.
    Hum Vaccin Immunother; 2022 Nov 30; 18(5):2050653. PubMed ID: 35344679
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.
    Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M.
    BMC Med; 2017 Sep 08; 15(1):166. PubMed ID: 28882149
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.
    Vaccine; 2008 Jun 02; 26(23):2841-8. PubMed ID: 18462851
    [Abstract] [Full Text] [Related]

  • 9. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct 06; 56(10):1356-1386. PubMed ID: 36274602
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model.
    Crépey P, Boiron L, Araujo RR, Lopez JG, Petitjean A, de Albuquerque Luna EJ.
    BMC Public Health; 2020 Sep 09; 20(1):1374. PubMed ID: 32907562
    [Abstract] [Full Text] [Related]

  • 13. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct 10; 43(10):1515-1544. PubMed ID: 36456484
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
    Bellier L, Petitjean A, Sarazu T, Tresierra J, Lopez JG.
    Vaccine; 2021 Jul 05; 39(30):4144-4152. PubMed ID: 34130885
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ, Talbird SE, Davis AE, Thommes EW, Meier G.
    Hum Vaccin Immunother; 2017 Mar 04; 13(3):533-542. PubMed ID: 27780425
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
    Crépey P, Redondo E, Díez-Domingo J, Ortiz de Lejarazu R, Martinón-Torres F, Gil de Miguel Á, López-Belmonte JL, Alvarez FP, Bricout H, Solozabal M.
    PLoS One; 2020 Mar 04; 15(5):e0233526. PubMed ID: 32437476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.